Sorrento gets US FDA nod for mRNA Covid-19 vaccine trial; One Peak closes $1 bln
Sorrento Therapeutics has received clearance from the US FDA to initiate clinical trials with its new mRNA vaccine against Omicron variants of the Coronavirus. One Peak, an investor in growth-stage B2
Dec 07, 2022, 09:27 IST
More Podcasts
- Home /
- Podcast /
- Forbes-india-daily-tech-brief-podcast /
- Sorrento-gets-us-fda-nod-for-mrna-covid19-vaccine-trial-one-peak-closes-1-bln-fund-neureality-raises-35-mln